SLC26A6 and ischemia: In the current study, we directly demonstrated that ablation of Slc26a6 reduced acid loading and increased pHi in cardiomyocytes [22] and in ex vivo hearts (Figure 7B), while the fall of cardiac pHi in Slc26a6−/− mice during ischemia may be ameliorated compared to WT mice.